Zain Khalpey: New Perspectives on Cardiovascular Risk in Women’s Health
Zain Khalpey, Chief Medical AI Officer, Chair of Applied Clinical AI, Director, Khalpey AI Lab at ATARI AI, shared a post on LinkedIn about a paper by Yolande Appelman et al. published in European Heart Journal:
“Cardiovascular disease is the leading cause of death in women, yet it is still underrecognized and often diagnosed too late.
This European Heart Journal review highlights how traditional risk factors interact with sex specific factors such as pregnancy complications, menopause, autoimmune disease, and hormonal changes that begin as early as the premenopausal years.
The authors call for a shift toward lifelong, sex specific prevention, earlier detection of preclinical disease, and tailored treatment pathways to reduce cardiovascular risk in women.
Read the full article.
Follow Zain Khalpey for more on Ai and Healthcare.”
Title: Cardiovascular disease in women: traditional and sex-specific risk factors
Authors: Yolande Appelman, Martha Gulati, Jeanine E Roeters van Lennep, Leslee J Shaw, C Noel Bairey Merz

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 7, 2026, 16:23Amelia Degenkolb: ACOG 2026 Brings Innovation, Partnership and Patient Access Into Focus
-
May 7, 2026, 16:15New FIGO-IPPS Classification for Female Chronic Pelvic Pain – IJGO
-
May 7, 2026, 16:05Marco Zaccaria: How Uterine Fibroids Affect Latina Women
-
May 7, 2026, 12:36Adela Serban: Advanced Imaging Technique Enhances Uterine Imaging with 3D Ultrasound and Uterine Tracing
-
May 7, 2026, 12:26David Sable Highlights The Quest for Fertility as a Deep and Valuable Read
-
May 7, 2026, 12:20May Is Preeclampsia Awareness Month – The Society for Maternal-Fetal Medicine
-
May 7, 2026, 12:15PCOS Symptoms Should Not Be Dismissed – PCOS Awareness Association
-
May 7, 2026, 12:08Marco Zaccaria: The Role of the Junctional Zone in the Management of Adenomyosis With Infertility
-
May 7, 2026, 12:04Emad Sedeek: Understanding the Differences in PGT-A, PGT-M and PGT-P Embryogenetic Testing
